BML Capital Management, LLC

Holdings History for Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN)

Symbol: ELVN on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2024		-0.59%	$0	0	-50,100	-100%	$29.62	Q2 2024
31 Mar 2024	0.59%	+0%	$881,259	50,100	+100	+0.2%	$17.59	Q1 2024
31 Dec 2023	0.55%	0%	$692,000	50,000	0		$13.84	Q4 2023
30 Sep 2023	0.63%	-0.31%	$683,000	50,000	-24,232	-33%	$13.66	Q3 2023
30 Jun 2023	1.4%	-2.5%	$1,515,075	74,232	-137,947	-65%	$20.41	Q2 2023
31 Mar 2023	4%	+4%	$4,646,720	212,179	+212,179	NEW	$21.90	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.